| Physicochemical characteristics and in vitro toxicity/anti-SARS-CoV-2 activity of favipiravir solid lipid nanoparticles (SLNs) AS Tulbah, WH Lee Pharmaceuticals 14 (10), 1059, 2021 | 31 | 2021 |
| Dry powder formulation of simvastatin AS Tulbah, HX Ong, L Morgan, P Colombo, PM Young, D Traini Expert opinion on drug delivery 12 (6), 857-868, 2015 | 29 | 2015 |
| Inhaled simvastatin nanoparticles for inflammatory lung disease AS Tulbah, E Pisano, S Scalia, PM Young, D Traini, HX Ong Nanomedicine 12 (20), 2471-2485, 2017 | 26 | 2017 |
| Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative … A Sheikh, MAS Abourehab, AS Tulbah, P Kesharwani Journal of Drug Delivery Science and Technology 86, 104745, 2023 | 25 | 2023 |
| In vitro and in vivo evaluation of the effectiveness and safety of amygdalin as a cancer therapy FIA El-Ela, A Gamal, HA Elbanna, AH ElBanna, HF Salem, AS Tulbah Pharmaceuticals 15 (11), 1306, 2022 | 24 | 2022 |
| Enhancing the bioavailability and efficacy of vismodegib for the control of skin cancer: in vitro and in vivo studies HF Salem, A Gamal, H Saeed, M Kamal, AS Tulbah Pharmaceuticals 15 (2), 126, 2022 | 24 | 2022 |
| Novel simvastatin inhalation formulation and characterisation AS Tulbah, HX Ong, P Colombo, PM Young, D Traini AAPS PharmSciTech 15, 956-962, 2014 | 23 | 2014 |
| The impact of improving dermal permeation on the efficacy and targeting of liposome nanoparticles as a potential treatment for breast cancer HF Salem, A Gamal, H Saeed, AS Tulbah Pharmaceutics 13 (10), 1633, 2021 | 22 | 2021 |
| Biological effects of simvastatin formulated as pMDI on pulmonary epithelial cells AS Tulbah, HX Ong, WH Lee, P Colombo, PM Young, D Traini Pharmaceutical research 33, 92-101, 2016 | 20 | 2016 |
| Design and characterization of atorvastatin dry powder formulation as a potential lung cancer treatment AS Tulbah, A Gamal Saudi Pharmaceutical Journal 29 (12), 1449-1457, 2021 | 16 | 2021 |
| The potential of Atorvastatin for chronic lung diseases therapy AS Tulbah Saudi Pharmaceutical Journal 28 (11), 1353-1363, 2020 | 16 | 2020 |
| Simvastatin nanoparticles reduce inflammation in LPS-stimulated alveolar macrophages AS Tulbah, E Pisano, E Landh, S Scalia, PM Young, D Traini, HX Ong Journal of pharmaceutical sciences 108 (12), 3890-3897, 2019 | 16 | 2019 |
| Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons AS Tulbah, HX Ong, P Colombo, PM Young, D Traini Expert opinion on drug delivery 13 (10), 1407-1420, 2016 | 15 | 2016 |
| Inhaled atorvastatin nanoparticles for lung cancer AS Tulbah Current Drug Delivery 19 (10), 1073-1082, 2022 | 14 | 2022 |
| Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures AS Tulbah, MH Elkomy, RM Zaki, HM Eid, EM Eissa, AA Ali, HA Yassin, ... International journal of pharmaceutics: X 6, 100206, 2023 | 13 | 2023 |
| In vitro bio-characterization of solid lipid nanoparticles of favipiravir in A549 human lung epithelial cancer cells AS Tulbah Journal of Taibah University Medical Sciences 18 (5), 1076-1086, 2023 | 8 | 2023 |
| Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis SA Hazari, A Sheikh, MAS Abourehab, AS Tulbah, P Kesharwani Environmental Research 234, 116562, 2023 | 7 | 2023 |
| Formulation and therapeutic evaluation of isoxsuprine-loaded nanoparticles against diabetes-associated stroke HA Abou-Taleb, BN Aldosari, RM Zaki, O Afzal, AS Tulbah, MG Shahataa, ... Pharmaceutics 15 (9), 2242, 2023 | 7 | 2023 |
| Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers HA Abo El-Enin, AS Tulbah, HW Darwish, R Salama, IA Naguib, ... Pharmaceuticals 16 (6), 886, 2023 | 6 | 2023 |
| In vitro evaluation of nebulized eucalyptol nano-emulsion formulation as a potential COVID-19 treatment AS Tulbah, A Bader, HX Ong, D Traini Saudi Pharmaceutical Journal 30 (12), 1691-1699, 2022 | 6 | 2022 |
